Optiscan adds $5M tranche for glucose monitor
Optiscan Biomedical, developer of a less-invasive human glucose monitor for hospitals, received an additional $5 million in a second round of funding that now totals $53 million. The boost came from Wexford Capital, reports VentureWire.
The Hayward, Calif.-based company plans to use its new resources to see its product through clinical trials next year. While it has already been tested on humans, it has yet to receive the stamp of approval from the Food and Drug… Continue Reading
BioImagene adds Siemens funding for digital pathology
Digital pathology developer BioImagene brought Siemens Venture Capital into its fold last week, adding an unreleased amount to a recently-closed $26 million fourth-round of financing. That round was led by Burill & Co. and included Ascension Health Ventures, National Healthcare Services, Artiman Ventures and ICCP Ventures.
The Cupertino, Calif.-based company helps laboratories view, manage and analyze images of pathologies. It provides tools to turn microscope slides into high-resolution images that can then be shared and transferred… Continue Reading
Life sciences briefing: Thursday, Feb. 21, 2008
TODAY’S HEADLINES:
Compact ultrasound maker Zonare Medical raises $30M (VentureWire)
TherOx raises $30M for hypersaturated-oxygen devices (peHUB)
Accumetrics, antiplatelet-drug diagnostic maker, raises $29M (release)
Population Genetics takes in £3.8M for massively parallel genome studies (GenomeWeb)
“Brain fitness” trainer Dakim raises $11M (release)
BioIQ, home-diagnostics maker, takes in $2.5M (release)
Hospital med-tracker Sabal Medical raises funds (release)
Seattle’s PharmaIN gets $400K NIH grant for nanoparticle staph drug (PDF release)
SensiGen, molecular-diagnostics developer, receives Michigan state loan (release)
Arcus Ventures aims for $50M fund, targets cancer (VentureWire)
Compact… Continue Reading
Life sciences briefing: Wednesday, Aug. 15, 2007
(UPDATED at 5:55pm PT: See below.)
Featured companies: Sierra Surgical Technologies, HerbalScience Nutraceuticals, Topigen Pharmaceuticals, EKR Therapeutics, Molecular Partners, Celsense, Glucose Sensing Technologies, Falcon Genomics, Waters, Calorimetry Sciences, Parion Sciences, Gilead Sciences, Isto Technologies, Fluidnet, NABsys
Sierra Surgical raises $7.1M — Palo Alto, Calif.-based Sierra Surgical Technologies, a developer of female sterilization technology, raised $7.1 million in a first funding round, PE Hub reports, citing a regulatory filing. Alta Partners and De Novo Ventures provided the funding.
Singapore’s HerbalScience raises… Continue Reading
Implant maker Interventional Spine draws in $24M
Irvine, Calif.-based Interventional Spine raised $24 million in a third round of funding that the company says will support the launch of several new products. The company makes implants and surgical instruments for “percutaneous” spinal operations that feature narrow incisions and, theoretically, less trauma for patients. Here is the company’s release.
Ascension Health Ventures led the round, joined by Wexford Capital, HBM BioVentures, Rock Creek Capital, the MedFocus Fund and a group of current investors.
TomoTherapy, cancer-treatment system maker, gets enthusiastic IPO reception
TomoTherapy, a Madison, Wis.-based maker of imaging and radiation-treatment systems for cancer therapy, raised $222.3 million in an initial offering after its shares priced higher than the company’s original range.
TomoTherapy shares, which now trade under the symbol TTPY, priced at $19, well above the company’s expected range of $15 to $17, yielding net proceeds to the company of roughly $185 million. The stock opened this morning at $24. TomoTherapy makes and sells integrated devices that… Continue Reading